Blueprint Medicines Statistics
Total Valuation
BPMC has a market cap or net worth of $7.20 billion. The enterprise value is $6.87 billion.
| Market Cap | 7.20B |
| Enterprise Value | 6.87B |
Important Dates
The next confirmed earnings date is Thursday, August 1, 2024, before market open.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BPMC has 62.62 million shares outstanding. The number of shares has increased by 6.11% in one year.
| Shares Outstanding | 62.62M |
| Shares Change (YoY) | +6.11% |
| Shares Change (QoQ) | +4.77% |
| Owned by Insiders (%) | 0.92% |
| Owned by Institutions (%) | 107.28% |
| Float | 61.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.51 |
| Forward PS | 15.08 |
| PB Ratio | 23.17 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 1.06.
| Current Ratio | 3.76 |
| Quick Ratio | 3.48 |
| Debt / Equity | 1.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.25 |
Financial Efficiency
Return on equity (ROE) is -120.70% and return on invested capital (ROIC) is -68.80%.
| Return on Equity (ROE) | -120.70% |
| Return on Assets (ROA) | -26.80% |
| Return on Capital (ROIC) | -68.80% |
| Revenue Per Employee | $430,853 |
| Profits Per Employee | -$440,131 |
| Employee Count | 655 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.48 |
Taxes
In the past 12 months, BPMC has paid $628,000 in taxes.
| Income Tax | 628,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +99.71% in the last 52 weeks. The beta is 0.63, so BPMC's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +99.71% |
| 50-Day Moving Average | 107.87 |
| 200-Day Moving Average | 85.88 |
| Relative Strength Index (RSI) | 57.23 |
| Average Volume (20 Days) | 694,315 |
Short Selling Information
The latest short interest is 4.56 million, so 7.28% of the outstanding shares have been sold short.
| Short Interest | 4.56M |
| Short Previous Month | 4.40M |
| Short % of Shares Out | 7.28% |
| Short % of Float | 7.36% |
| Short Ratio (days to cover) | 7.40 |
Income Statement
In the last 12 months, BPMC had revenue of $282.21 million and -$288.29 million in losses. Loss per share was -$4.81.
| Revenue | 282.21M |
| Gross Profit | 270.69M |
| Operating Income | -440.89M |
| Pretax Income | -287.66M |
| Net Income | -288.29M |
| EBITDA | -246.69M |
| EBIT | -268.79M |
| Loss Per Share | -$4.81 |
Balance Sheet
The company has $658.54 million in cash and $330.11 million in debt, giving a net cash position of $328.42 million or $5.24 per share.
| Cash & Cash Equivalents | 658.54M |
| Total Debt | 330.11M |
| Net Cash | 328.42M |
| Net Cash Per Share | $5.24 |
| Equity (Book Value) | 310.69M |
| Book Value Per Share | 4.96 |
| Working Capital | 570.00M |
Cash Flow
In the last 12 months, operating cash flow was -$415.40 million and capital expenditures -$14.58 million, giving a free cash flow of -$429.98 million.
| Operating Cash Flow | -415.40M |
| Capital Expenditures | -14.58M |
| Free Cash Flow | -429.98M |
| FCF Per Share | -$6.98 |
Margins
Gross margin is 95.92%, with operating and profit margins of -156.23% and -102.15%.
| Gross Margin | 95.92% |
| Operating Margin | -156.23% |
| Pretax Margin | -101.93% |
| Profit Margin | -102.15% |
| EBITDA Margin | -87.41% |
| EBIT Margin | -95.25% |
| FCF Margin | -152.36% |
Dividends & Yields
BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.11% |
| Shareholder Yield | -6.11% |
| Earnings Yield | -4.00% |
| FCF Yield | -5.97% |
Analyst Forecast
The average price target for BPMC is $116.33, which is 1.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $116.33 |
| Price Target Difference | 1.18% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (5Y) | 39.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BPMC has an Altman Z-Score of 2.98 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.98 |
| Piotroski F-Score | 2 |